Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

VK100 Percutaneous Vertebral Augmentation System

K-Number: K192403 · 2019-11-08

ApplicantBonwrx, Ltd.
Decision Date2019-11-08
Product CodeNDN
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

VK100 Percutaneous Vertebral Augmentation System is a medical device manufactured by Bonwrx, Ltd.. It received FDA 510(k) clearance on 2019-11-08 under approval number K192403. The device is classified under product code NDN. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the VK100 Percutaneous Vertebral Augmentation System?

VK100 Percutaneous Vertebral Augmentation System is a medical device that received FDA 510(k) clearance on 2019-11-08. It is manufactured by Bonwrx, Ltd.. The 510(k) number is K192403.

When was VK100 Percutaneous Vertebral Augmentation System approved by the FDA?

VK100 Percutaneous Vertebral Augmentation System received FDA 510(k) clearance on 2019-11-08, under approval number K192403.

What company makes VK100 Percutaneous Vertebral Augmentation System?

VK100 Percutaneous Vertebral Augmentation System is manufactured by Bonwrx, Ltd..

What is the FDA product code for VK100 Percutaneous Vertebral Augmentation System?

The FDA product code for VK100 Percutaneous Vertebral Augmentation System is NDN.

Related Clinical Trials

Related PubMed Literature

Related Devices (Code: NDN)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.